Hosted on MSN10mon
CAR T cell therapy for T cell lymphoma shows promise in phase I trialThe CAR T cell therapy in this phase I trial uses the patient's own T cells, modified in the lab to target the CD5 protein, which is highly expressed in T cell lymphoma and in normal T cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback